Nx Gen Sequencing Amyotrophic Lateral Sclerosis Test sale cost 4680 AED
POLG Gene Alper's Syndrome Genetic Test sale cost 4400 AED POLG Gene Alper's Syndrome Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Ganglioside GM-1 Antibodies IgG and IgM Test sale cost 3300 AED Ganglioside GM-1 Antibodies IgG and IgM Test Cost 4,800 د.إ Original price was: 4,800 د.إ.3,300 د.إCurrent price is: 3,300 د.إ.
Sale!

Nx Gen Sequencing Amyotrophic Lateral Sclerosis Test Cost

Original price was: 5,200 د.إ.Current price is: 4,680 د.إ.

-10%

The “Nx Gen Sequencing Amyotrophic Lateral Sclerosis (ALS) Test” offered by DNA Labs UAE is a cutting-edge diagnostic tool designed to identify genetic markers associated with ALS, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord, leading to loss of muscle control. Priced at 4680 AED, this comprehensive test leverages Next-Generation Sequencing (NGS) technology to analyze multiple genes simultaneously, providing a detailed genetic profile that helps in understanding an individual’s risk of developing ALS. This high-throughput approach not only enhances the accuracy of diagnosis but also significantly reduces the time needed to obtain results, thereby facilitating early intervention and personalized management plans for patients. Conducted in the state-of-the-art facilities of DNA Labs UAE, this test represents a crucial step forward in the fight against ALS, offering hope and crucial information to individuals and families affected by this condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test

At DNA Labs UAE, we offer the Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test to diagnose and understand the genetic causes of ALS. This neurodegenerative disease affects nerve cells in the brain and spinal cord, leading to the progressive loss of muscle control and eventual paralysis.

Test Components

The Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test includes the following components:

  • ALS2
  • ANG
  • ATXN2
  • C9orf72
  • CHCHD10
  • CHMP2B
  • DCTN1
  • ERBB4
  • FIG4
  • FUS
  • HNRNPA1
  • MATR3
  • NEFH
  • OPTN
  • PFN1
  • PRPH
  • SETX
  • SIGMAR1
  • SMN1
  • SOD1
  • SPG11
  • SQSTM1
  • TARDBP
  • TBK1
  • TRPM7
  • TUBA4A
  • UBQLN2
  • VAPB
  • VCP

Test Cost

The cost of the Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test is AED 4680.0.

Sample Condition

To conduct the test, we require 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. The sample should be shipped refrigerated and should not be frozen. Additionally, a duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.

Report Delivery

The sample should be submitted daily by 9 am, and the report will be delivered within 40 working days.

Method

The Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test utilizes Next-generation sequencing (NGS) and Sanger sequencing methods.

Test Type

The Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test falls under the category of Genetic Disorders-Progressive Motor Neuron Disease.

Doctor

The test is recommended to be conducted under the supervision of a neurologist.

Test Department

The test is conducted in our Molecular Diagnostics department.

Pre Test Information

A duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory before conducting the test.

Test Details

Next-generation sequencing (NGS) is a powerful diagnostic tool for Amyotrophic lateral sclerosis (ALS). It allows for rapid and cost-effective sequencing of large amounts of DNA or RNA. In the case of ALS, NGS can identify genetic mutations associated with the disease, such as SOD1, C9orf72, TARDBP, and FUS. By sequencing these genes, the test can detect any mutations or variations that may be present, aiding in the diagnosis of ALS and providing insights into its genetic causes.

NGS also has research applications for studying the genetic basis of ALS and identifying potential therapeutic targets. By sequencing the entire genome or transcriptome of individuals with ALS, researchers can gain a comprehensive understanding of the genetic changes that occur in the disease, leading to the development of new treatment strategies.

Overall, NGS has revolutionized the field of genetics and has the potential to greatly impact the diagnosis and treatment of ALS. It provides a more comprehensive and detailed view of an individual’s genetic makeup, improving our understanding of the disease and ultimately leading to better patient care.

Test Name Nx GEN SEQUENCING AMYOTROPHIC LATERAL SCLEROSIS Test
Components ALS2, ANG, ATXN2, C9orf72, CHCHD10, CHMP2B, DCTN1, ERBB4, FIG4, FUS, HNRNPA1, MATR3, NEFH, OPTN, PFN1, PRPH, SETX, SIGMAR1, SMN1, SOD1, SPG11, SQSTM1, TARDBP, TBK1, TRPM7, TUBA4A, UBQLN2, VAPB, VCP
Price 4680.0 AED
Sample Condition Submit 10 mL (5 mL min.) whole blood from 2 Lavender Top (EDTA) tubes. Ship refrigerated. DO NOT FREEZE. Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Report Delivery Sample Daily by 9 am; Report 40 Working days
Method NGS, Sanger sequencing
Test type Genetic Disorders-Progressive Motor Neuron Disease
Doctor Neurologist
Test Department: MOLECULAR DIAGNOSTICS
Pre Test Information Duly filled Whole Exome Sequencing Consent Form (Form 37) is mandatory.
Test Details

Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disease that affects nerve cells in the brain and spinal cord. It leads to the progressive loss of muscle control, eventually resulting in paralysis and death.

Next-generation sequencing (NGS) can be used as a diagnostic tool for ALS. NGS technologies allow for the rapid and cost-effective sequencing of large amounts of DNA or RNA. In the case of ALS, NGS can be used to identify genetic mutations that are associated with the disease.

There are several genes that have been linked to ALS, including SOD1, C9orf72, TARDBP, and FUS. NGS can be used to sequence these genes and identify any mutations or variations that may be present. This information can help with the diagnosis of ALS and also provide valuable insights into the underlying genetic causes of the disease.

In addition to diagnostic applications, NGS can also be used for research purposes to study the genetic basis of ALS and identify potential therapeutic targets. By sequencing the entire genome or transcriptome of individuals with ALS, researchers can gain a comprehensive understanding of the genetic changes that occur in the disease and potentially develop new treatment strategies.

Overall, NGS has revolutionized the field of genetics and has the potential to greatly impact the diagnosis and treatment of ALS. By providing a more comprehensive and detailed view of an individual’s genetic makeup, NGS can help improve our understanding of the disease and ultimately lead to better patient care.

SKU: TEST-4619 Category:

Related products